Algorithme Pharma

Algorithm changes name, updates acuity solution

Monday, August 10, 2015

Algorithm, a global provider of clinical analytics solutions and software, has released the latest version of its acuity solution, designed for use by pharma, biotech, CRO and academic organizations to drive regulatory compliant processes around management of risk. The acuity solution allows organizations to assess and capture the risk profile for a clinical trial and map risks to intelligent actions as part of the risk-based monitoring paradigm.

[Read More]

Algorithme Gets 240 Bed Phase I Unit from BASi

Thursday, July 10, 2008

Bioanalytical Systems (BASi) sold its Baltimore-based clinical pharmacology research unit to Montreal, Canada-based phase I/bioequivalence CRO Algorithme. BASi sold the 68,000-square-foot, 240-bed unit for $850,000 in cash. Since it is BASi’s only early phase research facility, BASi is exiting the phase I first-in-human clinical trials market. The company is primarily a preclinical, bioanalytical and immuno-assay services firm. It also manufactures specialized equipment for liquid chromatography, in vivo sampling, veterinary medicine and electrochemistry.

[Read More]